Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01091038 · ClinicalTrials.gov registry record · Phase 2

Improving Safety by Basic Computerizing Outpatient Prescribing

A Phase 2 study of Adverse Drug Events, sponsored by Indiana University.

Completed
Registry status
Phase 2
Development phase
228
Enrollment target
2
Study locations

NCT01091038 is a Phase 2 study of Adverse Drug Events that has completed, run by Indiana University. The registered enrollment target is 228 participants, below the 751-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (70% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01091038, a Phase 2 study of Adverse Drug Events, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 2
Development phase
228 participants
Enrollment target
2
Study locations

Study Summary

The study will measure the effect of basic clinical decision support on medical errors and adverse drug events in the ambulatory setting.

Conditions Studied

Adverse Drug Events

Interventions

  • OTHER Routine Care
  • OTHER Basic Clinical Decision Support

Study Locations (2)

Indiana

  • Wishard Helath Services - Indianapolis

Massachusetts

  • Partner's Healthcare - Boston

Trial Details

FieldValue
Enrollment Target 228 participants
Start Date 2001-08
Est. Completion 2007-08
Phase Phase 2

Sponsor

Indiana University

890 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01091038

The ClinicalTrials.gov registry entry for NCT01091038 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 751-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (70% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Adverse Drug Events appearing as the primary indexed condition, and to 2 interventions - of which Routine Care is the first listed.

NCT01091038 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01091038 about?

NCT01091038 is a clinical study titled "Improving Safety by Basic Computerizing Outpatient Prescribing". The study will measure the effect of basic clinical decision support on medical errors and adverse drug events in the ambulatory setting.

What is the current status of trial NCT01091038?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 228 participants. The study started on 2001-08. Estimated completion is 2007-08.

What conditions does trial NCT01091038 study?

This clinical trial studies the following conditions: Adverse Drug Events.

What interventions are being tested in trial NCT01091038?

The interventions under investigation include: Routine Care (OTHER), Basic Clinical Decision Support (OTHER).

Who is sponsoring clinical trial NCT01091038?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01091038 being conducted?

This trial has 2 study locations across Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Adverse Drug Events

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Adverse Drug Events

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.